Home
Cancer types
Treatments
Support
News
Centres and oncologists
Search
Wednesday, November 11, 2026
Ogkologos.com
Home
Cancer types
Treatments
Support
News
Centres and oncologists
Home
Authors
Posts by Ogkologos
Ogkologos
4396 POSTS
0 COMMENTS
EMA Recommends Granting a Marketing Authorisation for Zolbetuximab
Ogkologos
-
August 28, 2024
0
FDA Approves Engineered Cell Therapy for Advanced Synovial Sarcoma
Ogkologos
-
August 27, 2024
0
Adding Upfront SRS to CNS-penetrant TKI Improves Time-to-CNS Progression and Local...
Ogkologos
-
August 27, 2024
0
Comprehensive Genomic Profiling with Molecularly-Guided Therapy Results in Longer PFS Compared...
Ogkologos
-
August 26, 2024
0
EMA Recommends Extension of Therapeutic Indications for Encorafenib and Binimetinib
Ogkologos
-
August 23, 2024
0
To Combat Cancer Treatment Resistance, Researchers Try Leveraging Evolution
Ogkologos
-
August 22, 2024
0
Superior Prognostic Accuracy of Integrated 15-GEP/PRAME Classifier Over 15-GEP Alone in...
Ogkologos
-
August 22, 2024
0
EMA Recommends Granting a Marketing Authorisation for Toripalimab
Ogkologos
-
August 21, 2024
0
Can Chemo Help KRAS Inhibitors Work Better Against Pancreatic Cancer?
Ogkologos
-
August 20, 2024
0
Preliminary Evidence of Efficacy of an Upfront ICI-based Therapeutic Strategy in...
Ogkologos
-
August 20, 2024
0
1
...
72
73
74
...
440
Page 73 of 440
MOST POPULAR
EMA Recommends Granting a Conditional Marketing Authorisation for Sotorasib
November 22, 2021
Mom Is Warning Other Parents After Her Son Was Bit By...
May 24, 2019
EMA Recommends Extension of Indications for Ibrutinib
September 11, 2025
Binimetinib Contributes to the Efficacy and Safety Outcomes Observed with Encorafenib...
September 4, 2023
Load more
HOT NEWS
Can Having Solar Panels or Living Near a Solar Farm Increase...
Hormone Therapy Has A Stronger Impact On A Woman’s Quality Of...
First-Line Triplet Combination of Zolbetuximab, mFOLFOX6 and Nivolumab Supports Targeting CLDN18.2...
Blood test could tailor treatment after surgery
Ελληνικά
English (UK)
